Cargando…
Early sofosbuvir-ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report
BACKGROUND: Hepatitis C virus (HCV) infection is a recognised cause of secondary immune thrombocytopenia (ITP). While its incidence has been largely described during chronic HCV infection, only one case of ITP secondary to acute HCV infection has been reported at this time. CASE PRESENTATION: We rep...
Autores principales: | Alcazer, Vincent, Miailhes, Patrick, Ramière, Christophe, Charre, Caroline, Cotte, Laurent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300032/ https://www.ncbi.nlm.nih.gov/pubmed/30567495 http://dx.doi.org/10.1186/s12879-018-3597-4 |
Ejemplares similares
-
Severe Steroid-responsive Skin Disorders Related to Ledipasvir and Sofosbuvir for HCV
por: Tadokoro, Tomoko, et al.
Publicado: (2017) -
Hepatitis C virus spread from HIV-positive to HIV-negative men who have sex with men
por: Charre, Caroline, et al.
Publicado: (2018) -
Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
por: Nirei, Kazushige, et al.
Publicado: (2017) -
The effectiveness of oral antiviral (Sofosbuvir/Ledipasvir) in treating children with HCV infection
por: Alkaaby, Ban Adil, et al.
Publicado: (2018) -
Quantifying transmission dynamics of acute hepatitis C virus infections in a heterogeneous population using sequence data
por: Danesh, Gonché, et al.
Publicado: (2021)